✦ LIBER ✦

Expression of FAS (CD95/APO-1) and FAS ligand in lung cancer, its prognostic and predictive relevance

✍ Scribed by Reet Koomägi; Manfred Volm

Publisher: John Wiley and Sons
Year: 1999
Tongue: French
Weight: 124 KB
Volume: 84
Category: Article
ISSN: 0020-7136
DOI: 10.1002/(sici)1097-0215(19990621)84:3<239::aid-ijc7>3.0.co;2-s

No coin nor oath required. For personal study only.

✦ Synopsis

FIGURE 1 -Immunoblot analyses identify 40 kDa (Fas) and 45 kDa (FasL) proteins.

📜 SIMILAR VOLUMES

Expression of Fas (APO-1/CD95) and Fas l

Expression of Fas (APO-1/CD95) and Fas ligand (FasL) in human neuroblastoma

✍ Gross, N. ;Balmas, K. ;Brognara, C. Beretta ;Tschopp, J. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 1 views

Soluble Fas (APO-1, CD95) and soluble Fa

Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases

✍ Kazuhisa Nozawa; Nobuhiko Kayagaki; Yoshiaki Tokano; Hideo Yagita; Ko Okumura; H 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB

Apoptosis, proliferation, and Fas (APO-1

Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast

✍ Evgeny Yakirevich; Lisa Maroun; Oded Cohen; Ofer Ben Izhak; Gad Rennert; Murray 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 1 views

Prognostic relevance of altered Fas (CD9

Prognostic relevance of altered Fas (CD95)-system in human breast cancer

✍ Marcella Mottolese; Simonetta Buglioni; Carla Bracalenti; Marco Andrea Cardarell 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 455 KB 👁 2 views

The Fas ligand (FasL) and its receptor Fas (APO-1 or CD95) are members, respectively, of the tumor necrosis factor family that, upon interaction with each other, play a key role in the initiation of one apoptotic pathway. Faulty regulation of the Fas system has been described in a variety of human t

Differential regulation of CD95 (Fas/APO

Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils

✍ Werner Luttmann; Alexander Opfer; Eva Dauer; Martin Foerster; Heinrich Matthys; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

Regulation of CD95 (APO-1/ FAS) ligand a

Regulation of CD95 (APO-1/ FAS) ligand and receptor expression in squamous-cell carcinoma by interferon-γ and cisplatin

✍ Cordula Moers; Ulrich Warskulat; Markus Müschen; Jos Even; Dieter Niederacher; R 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 337 KB 👁 2 views

CD95 (Apo-1/Fas) ligand (CD95L) expression has been observed in various malignancies. In human primary cell lines from a squamous cell carcinoma (SCC) of the vulva, the effect of cisplatin (CDDP) and IFN␥ on the expression of CD95L and its 2 receptor isoforms, CD95 transmembrane (CD95tm) and CD95 so